Sarcopenia-associated factors and their bone mineral density levels in middle-aged and elderly male type 2 diabetes patients

Table 1 General characteristics between type 2 diabetes mellitus patients and controls

	T2DM (n = 196)	Control (n = 60)	t	P value
Age (years)	72.06 ± 4.87	71.82 ± 4.28	0.349	0.723
Course of diabetes mellitus (years)	15.24 ± 2.08	-
BMI (kg/m2)	24.58 ± 2.47	25.04 ± 2.45	1.261	0.208
FBG (mmol/L)	9.69 ± 2.30	5.34 ± 0.60	14.49	< 0.0001
HbA1c (%)	9.14 ± 1.78	5.64 ± 0.85	14.74	< 0.0001
Total cholesterol (mmol/L)	4.27 ± 1.39	4.64 ± 1.03	1.897	0.059
Triglyceride (mmol/L)	1.73 ± 0.81	1.84 ± 0.61	0.967	0.335
High-density lipoprotein (mmol/L)	1.13 ± 0.30	1.26 ± 0.26	2.907	0.004
Low-density lipoprotein (mmol/L)	2.51 ± 0.92	2.86 ± 0.67	2.662	0.008
25(OH)D3 (ng/mL)	21.87 ± 7.85	31.42 ± 9.33	7.875	< 0.0001
Femoral neck BMD	0.76 ± 0.13	0.79 ± 0.12	1.469	0.143
Total hip BMD	0.87 ± 0.14	0.95 ± 0.11	3.855	0.0001
Lumbar spine L1-4 BMD	0.91 ± 0.20	0.97 ± 0.16	1.612	0.108

T2DM: Type 2 diabetes mellitus; BMD: Bone mineral density; BMI: Body mass index; FBG: Fasting blood glucose; HbA1c: Glycosylated hemoglobin.